BiomEdit, a pioneering animal health biotechnology company, today announced that the U.S. Department of Agriculture's Center for ...
, May 3, 2022 (Newswire.com) - Canalevia® Would Be the First and Only Treatment for EID in Dogs To Receive Any Type of Approval From FDA Jaguar Health, Inc. (NASDAQ:JAGX), under its Jaguar Animal ...
, February 10, 2022 (Newswire.com) - Canalevia â„¢ would be first and only FDA-approved plant-based medicine for working dogs that suffer from diarrhea Jaguar Health, Inc. (NASDAQ:JAGX), under its ...